Daiwa Securities Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-287
| Closed | -$17K | – | 1365 |
|
|
2023
Q4 | $17K | Buy |
287
+55
| +24% | +$3.26K | ﹤0.01% | 1132 |
|
|
2023
Q3 | $10K | Hold |
232
| – | – | ﹤0.01% | 1124 |
|
|
2023
Q2 | $8K | Hold |
232
| – | – | ﹤0.01% | 1144 |
|
|
2023
Q1 | $9K | Hold |
232
| – | – | ﹤0.01% | 1110 |
|
|
2022
Q4 | $11K | Buy |
232
+25
| +12% | +$1.19K | ﹤0.01% | 1106 |
|
|
2022
Q3 | $14K | Hold |
207
| – | – | ﹤0.01% | 1106 |
|
|
2022
Q2 | $14K | Buy |
207
+46
| +29% | +$3.11K | ﹤0.01% | 1121 |
|
|
2022
Q1 | $13K | Hold |
161
| – | – | ﹤0.01% | 1123 |
|
|
2021
Q4 | $24K | Sell |
161
-16
| -9% | -$2.39K | ﹤0.01% | 1105 |
|
|
2021
Q3 | $31K | Buy |
177
+77
| +77% | +$13.5K | ﹤0.01% | 1081 |
|
|
2021
Q2 | $16K | Hold |
100
| – | – | ﹤0.01% | 1024 |
|
|
2021
Q1 | $17K | Buy |
100
+5
| +5% | +$850 | ﹤0.01% | 1016 |
|
|
2020
Q4 | $21K | Sell |
95
-154
| -62% | -$34K | ﹤0.01% | 978 |
|
|
2020
Q3 | $41K | Buy |
249
+7
| +3% | +$1.15K | ﹤0.01% | 943 |
|
|
2020
Q2 | $19K | Hold |
242
| – | – | ﹤0.01% | 1013 |
|
|
2020
Q1 | $19K | Buy |
242
+19
| +9% | +$1.49K | ﹤0.01% | 1001 |
|
|
2019
Q4 | $29K | Sell |
223
-27
| -11% | -$3.51K | ﹤0.01% | 983 |
|
|
2019
Q3 | $19K | Buy |
250
+26
| +12% | +$1.98K | ﹤0.01% | 988 |
|
|
2019
Q2 | $23K | Hold |
224
| – | – | ﹤0.01% | 992 |
|
|
2019
Q1 | $16K | Sell |
224
-38
| -15% | -$2.71K | ﹤0.01% | 991 |
|
|
2018
Q4 | $11K | Buy |
+262
| New | +$11K | ﹤0.01% | 985 |
|